Search Results | Blood | American Society of Hematology

1-20 of 156

Sort by

Sort Order Select

Journal Articles

EBV: the virus that keeps on giving!

Mitchell S. Cairo

Blood (2023) 141 (7): 689–691.

DOI: https://doi.org/10.1182/blood.2022018748

Published: 2023

Journal Articles

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Michael A. Pulsipher, Kwang W. Ahn, Nancy J. Bunin, Nahal Lalefar, Eric Anderson, Allyson Flower, Mitchell S. Cairo, Julie-An Talano, Sonali Chaudhury, Carrie L. Kitko, Jamie L. Duke, Dimitrios Monos, Wing Leung, Christopher C. Dvorak, Hisham Abdel-Azim

Blood (2022) 140 (24): 2556–2572.

DOI: https://doi.org/10.1182/blood.2022015959

Published: 2022

Includes: Supplemental data

Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Temima Kanarfogel, Jessica C Hochberg, Emily Thatcher, Liana Klejmont, Yaya Chu, Qiuhu Shi, Allen J Dozor, Deborah Friedman, Harshini Mahanti, Erin Morris, Sandra Fabricatore, John DeFresne, Kenneth R. Cooke, Mitchell S Cairo

Blood (2022) 140 (Supplement 1): 2532–2534.

DOI: https://doi.org/10.1182/blood-2022-168299

Published: 2022

Journal Articles

Pilot Study Using Induction Chemo-Immunotherapy Followed By Consolidation with Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplant in Advanced Stage Mature Non-Anaplastic T- or NK-Cell Lymphoma/Leukemia in Children, Adolescent, and Young Adults

Ana C. Xavier, Lauren Harrison, Rodney R. Miles, Stephan Voss, Megan S. Lim, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 12029–12030.

DOI: https://doi.org/10.1182/blood-2022-160045

Published: 2022

Journal Articles

Fatalities from Tumor Lysis Syndrome (TLS) after Anti-Hyperuricemic Monotherapy - Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

Mitchell S Cairo, Jack R Gallagher, Yvonne Barnes, Edward Drea, Susan Carroll

Blood (2022) 140 (Supplement 1): 8136.

DOI: https://doi.org/10.1182/blood-2022-169864

Published: 2022

Journal Articles

Final Results of Phase I/II Trial of Mitoxantrone in Combination with Clofarabine (MITCL) in Children with Relapsed/Refractory Acute Leukemia

Jessica C Hochberg, Javier Oesterheld, Aliza Gardenswartz, Liana Klejmont, Jaclyn Basso, Elizabeth Mintzer, Lauren Harrison, Michael J Borowitz, Michael R. Loken, Mitchell S Cairo

Blood (2022) 140 (Supplement 1): 6140–6141.

DOI: https://doi.org/10.1182/blood-2022-167040

Published: 2022

Journal Articles

Survival of Patients with Extranodal NK-Cell Lymphoma in the United States

Ana C. Xavier, Nader Kim El-Mallawany, Matt J. Ehrhardt, Luciano J. Costa, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 6563–6564.

DOI: https://doi.org/10.1182/blood-2022-160023

Published: 2022

Journal Articles

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Mitchell S. Cairo, Mark A. Rocco, John Bernard, Satya R. Siddani, Apurvasena Parikh, Brian Elliott, Birgit Burkhardt

Blood (2022) 140 (Supplement 1): 3827–3828.

DOI: https://doi.org/10.1182/blood-2022-157546

Published: 2022

Journal Articles

Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model

Edo Schaefer, Yanling Liao, Morgan Anderson-Crannage, Bruno Hochberg, Hanif Mouehla, Jian Pan, Bernadette Fallon, Janet Ayello, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 8641–8642.

DOI: https://doi.org/10.1182/blood-2022-162820

Published: 2022

Journal Articles

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Blood (2021) 138 (Supplement 1): 3134.

DOI: https://doi.org/10.1182/blood-2021-147758

Published: 2021

Journal Articles

Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System

Blood (2021) 138 (Supplement 1): 476.

DOI: https://doi.org/10.1182/blood-2021-145620

Published: 2021

Journal Articles

IFN-γ Inhibitors and Ruxolitinib Therapy for Acquired Severe Aplastic Anemia in an Ex-Vivo Model

Edo Schaefer, Yanling Liao, Bernadette Fallon, Janet Ayello, Melanie Peters, Jian Pan, Morgan Anderson-Crannage, Mitchell S Cairo

Blood (2021) 138 (Supplement 1): 1123.

DOI: https://doi.org/10.1182/blood-2021-147079

Published: 2021

Journal Articles

First Reported Case Series of Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD)

Thomas A Gagliardi, Jordan Milner, Cassey Paula, Mehmet Ozkayank, Oya Levendoglu-Tugal, Jessica C. Hochberg, Jeremy Rosenblum, Aliza Gardenswartz, Mitchell S. Cairo, Amir Steinberg

Blood (2021) 138 (Supplement 1): 4885.

DOI: https://doi.org/10.1182/blood-2021-148071

Published: 2021

Journal Articles

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Elysia R. Cohen, Madeline Miceli, Jibran Ahmed, Alexandra Jimenez, Bruce Sachais, Delong Liu, Mitchell S. Cairo, Jeremy Rosenblum

Blood (2021) 138 (Supplement 1): 2148.

DOI: https://doi.org/10.1182/blood-2021-151259

Published: 2021

Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Blood (2021) 138 (Supplement 1): 3880.

DOI: https://doi.org/10.1182/blood-2021-148652

Published: 2021

Journal Articles

Rapid Engraftment, Immune Cell Reconstitution and Sustained Donor Chimerism in Patients Receiving G-CSF Mobilized Peripheral Blood Stem Cells (PB-SC) from Related or Unrelated Donors Undergoing CD34 Enrichment with Mononuclear Cell (T cell) Addback in Children, Adolescents, and Adults with Malignant and Nonmalignant Diseases

Jordan Milner, Cydney Nichols, Janet Ayello, MS, MT(ASCP), Karen P. Seiter, MD, Delong Liu, MD PhD, Erin Morris, RN, BSN, Sandra Fabricatore, RN, PNP, MSN, Yaya Chu, PhD, Rosemarie Shaw, Carmella van de Ven, MA, Allyson M. Flower, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 32–33.

DOI: https://doi.org/10.1182/blood-2020-137668

Published: 2020

Journal Articles

Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-g Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449)

Allyson M. Flower, MD, Rachel Friedmann, DO, Janet Ayello, MS, MT(ASCP), Olivia Rigot, PhD, Lauren Harrison, RN, MSN, Erin Morris, RN, BSN, Meghan Sturhahn, RN, MSN, Elana Maryamchik, MD, Yongping Wang, MD, Lynn O'Donnell, PhD, Rolla Abu-Arja, MD, Dean Anthony Lee, MD PhD, Julie-An Talano, MD, Bryon Johnson, PhD, Nancy Bunin, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 2–4.

DOI: https://doi.org/10.1182/blood-2020-140834

Published: 2020

Journal Articles

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Jessica C. Hochberg, MD, Stanton Goldman, MD, Matthew J. Barth, MD, Qiuhu Shi, PhD, Liana Klejmont, Pharm D, Lauren Harrison, RN, MSN, Jackie Basso, Yaya Chu, PhD, Humayun Islam, Perry Gerard, MD MBA, FACR, Javier Oesterheld, MD, Kenneth Matthew Heym, MD, Ivan I. Kirov, MD, Richard A. Drachtman, MD, Paul Harker-Murray, MD PhD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Bruce Shiramizu, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 3–4.

DOI: https://doi.org/10.1182/blood-2020-139464

Published: 2020

Journal Articles

Optimizing Ex-Vivo Expanded NK Cell- Mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) Combined with NKTR-255 in Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Burkitt Lymphoma (BL)

Yaya Chu, PhD, Susiyan Jiang, MS, Jian Jiang, MD, Meijuan Tian, PhD, Dean Anthony Lee, MD PhD, Loui Madakamutil, Mario Q. Marcondes, MDPhD, Christian Klein, PhD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 23–24.

DOI: https://doi.org/10.1182/blood-2020-139822

Published: 2020

Journal Articles

Preliminary Results of a Phase II Study to Determine the Safety of Defibrotide in Children and Adolescents with Sickle Cell Disease-Associated Acute Chest Syndrome (IND 127812)

Jordan Milner, MD, Deborah Friedman, MD, Marise D'Souza, MD MSc, Krishnan Sankaran, MD, Liana Klejmont, Pharm D, Erin Morris, RN, BSN, Harshini Mahanti, BS, MSCR, Neida Otero, Jessica C. Hochberg, MD, Adele Brudnicki, MD, Ken R. Cooke, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 8–9.

DOI: https://doi.org/10.1182/blood-2020-139617

Published: 2020

NARROW

EBV: the virus that keeps on giving!

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Pilot Study Using Induction Chemo-Immunotherapy Followed By Consolidation with Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplant in Advanced Stage Mature Non-Anaplastic T- or NK-Cell Lymphoma/Leukemia in Children, Adolescent, and Young Adults

Fatalities from Tumor Lysis Syndrome (TLS) after Anti-Hyperuricemic Monotherapy - Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

Final Results of Phase I/II Trial of Mitoxantrone in Combination with Clofarabine (MITCL) in Children with Relapsed/Refractory Acute Leukemia

Survival of Patients with Extranodal NK-Cell Lymphoma in the United States

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System

IFN-γ Inhibitors and Ruxolitinib Therapy for Acquired Severe Aplastic Anemia in an Ex-Vivo Model

First Reported Case Series of Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD)

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Optimizing Ex-Vivo Expanded NK Cell- Mediated Antibody-Dependent Cellular Cytotoxicity (ADCC) Combined with NKTR-255 in Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), and Burkitt Lymphoma (BL)

Preliminary Results of a Phase II Study to Determine the Safety of Defibrotide in Children and Adolescents with Sickle Cell Disease-Associated Acute Chest Syndrome (IND 127812)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only